Edward Holmes was vice chancellor for academic affairs and dean of the School of Medicine from 1999-2000 and now serves as CEO and president of the Sanford Consortium for Regenerative Medicine, vice chancellor and dean emeritus of University of San Diego Health Sciences, and Distinguished Professor at the University of California. During his time as dean, he says, he worked to build deeper and more effective collaborations not only within the health system but across the rest of campus — efforts that, among other things, helped elevate Duke to a leading position in the field of genome sciences.

A program led by Duke University School of Medicine students is helping people who have a history of homelessness make the transition to stable housing easier. In the process, the students are gaining a better understanding of the impact housing can have on health.

Duke Science and Technology Scholar Amy Gladfelter, PhD’01, a professor in the Department of Cell Biology, studies extremely large cells, such as that of the human placenta, whose outer layer is one huge cell with billions of nuclei. The insights she’s gaining into these cells’ organization and function sheds important light on cell biology, diseases of pregnancy, and cancer.

During his recent visit to Duke University, Dr. Anthony Fauci sat down with School of Medicine Dean Mary Klotman, MD, to discuss his long and storied career in public health, the history of HIV/AIDS and the progress being made to develop a vaccine to prevent it.

In experiments using mice and liver tissue from humans, Duke researchers identified how the aging process prompts certain liver cells to die off. They were then able to reverse the process in the animals with an investigational drug.

Barton F. Haynes, MD, HS’73-’75, is the Frederic M. Hanes Distinguished Professor of Medicine, professor of integrative immunology and global health and, for 34 years, director of the Duke Human Vaccine Institute (DHVI). He is an internationally recognized researcher who has expanded our understanding of fundamental immune regulation and its role in disease pathogenesis and vaccine development. Haynes’s early work on the biology of the thymus led to discoveries with Louise Markert, PhD’81, MD’82, HS’82-’87, that enabled successful thymus transplantation in children born without a thymus.

Denise Jamieson, MD'92, MPH, is vice president for medical affairs and dean of the Carver College of Medicine at the University of Iowa.

Emily Wang, MD'03, is a professor of internal medicine and public health at the Yale School of Medicine and Yale School of Public Health.

Sarah Wilson, PhD, always had an interest in fighting for justice and fairness, starting as early as high school. That drive to address inequities experienced by people in various communities still exists today. An assistant professor in psychiatry & behavioral sciences at Duke, she is involved with several projects, including a new intervention to mitigate racial implicit bias in clinicians.

In a column posted by American Scientist magazine, Duke Executive Vice President for Health Affairs and School of Medicine Dean Mary E. Klotman, MD; Adjunct Professor in Medicine Brian Southwell, PhD; and Tuckson Health Connections Managing Director Reed V. Tuckson address concerns about the increasing number of Americans who are declining even routine vaccinations due to medical misinformation and other factors.